ARCHIVES

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Korsmeyer Wins Bristol-Meyers Squibb Award; Lichter Names President-Elect of ASCO

April 18, 1997

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Researchers Identify Nine Cancer Genes-Five Linked to CLL For The First Time

December 30, 2011

Litton’s Government Contracts Status Under Review

September 6, 1985

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

Centers Ask Americans for $1 Each for Research.

May 16, 2008